Notably, IFN-β also inhibits the growth of melanoma cells by induction of cross-priming of CD8+ T cells by DCs in vitro and in vivo [34], and its antitumour effects against melanoma are generally better than IFN-α [35]. This evidence concerns the gene CD8A and melanoma.